ReviewEcancermedicalscience2026
Spatial omics and its applications for a tumour microenvironment characterization and precision medicine approach of gastric cancer.
Review in Ecancermedicalscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric cancer (GC) is a lethal disease due to heterogeneity and complexity from the point of view of epidemiology, epidemiology and public health policy and biological behaviour. Despite recent advances in the research field on the molecular and cellular characterisation of GC, the clinical outcomes have been ominous. Perhaps the unceasing research in future years, focusing on spatial omics, has revolutionary potential for transforming the conception and understanding of GC mechanisms, thereby enabling the discovery of targeted therapies that are most effective in improving survival. Under these circumstances, this review article lays the groundwork for an update of spatial omics, offering a comprehensive vision and its implications for understanding the landscape of GC research. Moreover, it highlights the recent advances and breakthroughs in heterogeneity and immunosuppressive tumour microenvironment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.